[CITATION][C] Renal Clearance of Technitium-99m-MAG3: Normal Values

CD Russell, Y Li, HN Kahraman… - Journal of Nuclear …, 1995 - Soc Nuclear Med
Dependson SpecificACtiVity Page 1 (MBq)RCP%n1591±22292.0%±1.452216±4493.8%±1.5942941±7894.3%±1.
Eq.2 In 15 preparations, the RCP was <90% and in 10 preparations <80% (Table 1). The …

Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.

JA Prenen, JM de Klerk, AD van het Schip… - Journal of Nuclear …, 1991 - europepmc.org
The renal clearance and distribution volume of 99Tc-mercaptoacetyltriglycine (MAG3) and
123I-o-iodohippurate (OIH) were determined separately in six normal male volunteers using …

Measurement of renal function with technetium-99m-MAG3 in children and adults

CD Russell, AT Taylor… - The Journal of Nuclear …, 1996 - search.proquest.com
relevant for the interpretation of "" ln-pentetreotide studies in Page 1 therapy. In addition. the
findings of this study may also be relevant for the interpretation of "" ln-pentetreotide studies in …

Pharmacokinetics of technetium-99m-MAG3 in humans.

B Bubeck, W Brandau, E Weber, T Kälble… - Journal of nuclear …, 1990 - europepmc.org
Technetium-99m-mercaptoacetylglycylglycylglycine (99mTc-MAG3) is introduced to replace
o-iodohippurate (OIH) for renal function studies. For interpretation of clinical findings …

Renal and extrarenal clearance of99mTc-MAG3: A comparison with125I-OIH and51Cr-EDTA in patients representing all levels of glomerular filtration rate

M Rehling, BV Nielsen, EB Pedersen… - European journal of …, 1995 - Springer
This investigation was undertaken in order to determine whether the clearance of
technetium-99m mercaptoacetyltriglycine (99m Tc-MAG 3) is more closely correlated to the …

Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases

K ITOH, E TSUKAMOTO, H KAKIZAKI… - Clinical nuclear …, 1993 - journals.lww.com
Abstract Tc-99m-labeled mercaptoacetyltriglycine (Tc-99m MAG3) is a recently introduced
radioagent that is excreted by tubular function. The aim of this study was to test Tc-99m …

Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.

L Kabasakal, HT Turoğlu, C Onsel, K Ozker… - Journal of Nuclear …, 1995 - europepmc.org
Methods After giving a 7.4 MBq 131I-OIH and 90-110 MBq 99mTc-EC or 99mTc-MAG3
bolus, a constant infusion (1MBq/ml 99mTc-agent and 0.07 MBq/m 131I-OIH was started …

[PDF][PDF] Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders

RA Jafri, KE Britton, CC Nimmon… - Journal of nuclear …, 1988 - Soc Nuclear Med
with Iodine- 123 and Iodine- 131 Orthoiodohippurate, in Patients with Renal Disorders Page
1 CLINICAL SCIENCES Technetium-99m MAG3, A Comparison with Iodine- 123 and Iodine …

[PDF][PDF] Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples

CD Russell, A Taylor, D Eshima - Journal of nuclear medicine, 1989 - Soc Nuclear Med
Estimation of Technetium-99m-MAG3 Plasma Clearance in Adults from One or Two Blood
Samples Page 1 he clinical value of quantitative renal function measurement is widely …

99mTc-MAG3: Dynamic studies in patients with renal disease

GH Schaap, THR Alferink, RBJ de Jong… - European journal of …, 1988 - Springer
Animal studies have suggested that 99m Tc-mercapto-acetylglycyl-glycyl-glycine (99m Tc-
MAG3) might be suitable for the determination of the renal plasma flow (RPF) because of its …